NDC 33342-087-02 - Rizatriptan
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 33342-087
- Requested NDC
- 33342-087-02
- Package NDCs from labels
- 33342-087-07, 33342-087-46, 33342-087-12, 33342-087-52, 33342-087-50, 33342-087-72, 33342-087-02, 33342-087-45, 33342-087-41
- Manufacturer
- Macleods Pharmaceuticals Limited
- Effective date
- 2022-07-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Rizatriptan - Macleods Pharmaceuticals Limited | Macleods Pharmaceuticals Limited | 2022-07-01 | Human Prescription Drug Label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 33342-087-02 | Rizatriptan | 6 in 1 BLISTER PACK | TABLET, FILM COATED | 6 | 7 | |
| 33342-087-07 | Rizatriptan | 30 in 1 CONTAINER | TABLET, FILM COATED | 30 | 7 | |
| 33342-087-12 | Rizatriptan | 10 in 1 CARTON | TABLET, FILM COATED | 10 | 7 | |
| 33342-087-12 | Rizatriptan | 10 in 1 BLISTER PACK | TABLET, FILM COATED | 10 | 7 | |
| 33342-087-41 | Rizatriptan | 3 in 1 CARTON | TABLET, FILM COATED | 3 | 7 | |
| 33342-087-45 | Rizatriptan | 2 in 1 CARTON | TABLET, FILM COATED | 2 | 7 | |
| 33342-087-46 | Rizatriptan | 200 in 1 CONTAINER | TABLET, FILM COATED | 200 | 7 | |
| 33342-087-50 | Rizatriptan | 4 in 1 CARTON | TABLET, FILM COATED | 4 | 7 | |
| 33342-087-52 | Rizatriptan | 3 in 1 BLISTER PACK | TABLET, FILM COATED | 3 | 7 | |
| 33342-087-72 | Rizatriptan | 6 in 1 CARTON | TABLET, FILM COATED | 6 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 33342-087-02 | EA - Each | 33342-087 | 31681628-355e-470e-ae71-322622e4e5a1 | 1 | 2019-01-24 |
| 33342-087-41 | EA - Each | 33342-087 | 80547782-d6fc-49fc-91c8-fe78fe1ab6ab | 1 | 2019-01-24 |
| 33342-087-45 | EA - Each | 33342-087 | d5783a19-55df-4d1f-ba86-e001fc6c22a3 | 1 | 2019-01-24 |
| 33342-087-50 | EA - Each | 33342-087 | 59084f09-5ae6-43cb-a683-12773e71b91a | 1 | 2015-02-02 |
| 33342-087-52 | EA - Each | 33342-087 | c8d774c2-5553-48ec-9366-3d8ed57f0f40 | 1 | 2018-12-13 |
| 33342-087-72 | EA - Each | 33342-087 | c1755e9d-1add-4b22-9480-435853e9f729 | 1 | 2015-02-02 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| RIZATRIPTAN BENZOATE | ACTIVE INGREDIENT | WR978S7QHH | RIZATRIPTAN TABLET, FILM COATED [MACLEODS PHARMACEUTICALS LIMITED] | 2 | |
| RIZATRIPTAN | ACTIVE MOIETY | 51086HBW8G | RIZATRIPTAN TABLET, FILM COATED [MACLEODS PHARMACEUTICALS LIMITED] | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | RIZATRIPTAN TABLET, FILM COATED [MACLEODS PHARMACEUTICALS LIMITED] | 2 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | RIZATRIPTAN TABLET, FILM COATED [MACLEODS PHARMACEUTICALS LIMITED] | 2 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | RIZATRIPTAN TABLET, FILM COATED [MACLEODS PHARMACEUTICALS LIMITED] | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | RIZATRIPTAN TABLET, FILM COATED [MACLEODS PHARMACEUTICALS LIMITED] | 2 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | RIZATRIPTAN TABLET, FILM COATED [MACLEODS PHARMACEUTICALS LIMITED] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rizatriptan | RIZATRIPTAN | Bryant Ranch Prepack | f000d96c-42a0-4aac-96ca-8cef289979ce | 2025-11-26 | Warnings, Adverse reactions | ANDA203147 314209 WR978S7QHH |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS SPRAY | Kroger Co. | 6b3e7aac-395f-48cf-9c5e-f7e163724aef | 2025-11-17 | Warnings | 1K09F3G675 |
| Au Kah Chuen Fugical | CALAMINE AND DIPHENHYDRAMINE HYDROCHLORID | Zhejiang Dingtai Pharmaceutical Co., Ltd | 5b4add17-6c3d-4093-826a-2edb41c1d1db | 2025-11-10 | Warnings | 1K09F3G675 |
| FARGELIN HEMORRHOIDAL | CALAMINE, PETROLATUM AND PHENYLEPHRINE HYDROCHLORIDE | MADISON ONE ACME INC | 6844ad63-512d-496a-9458-011894185b0d | 2025-11-10 | Warnings | 1K09F3G675 |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Bryant Ranch Prepack | 6391d2a1-252e-4e50-9d80-4dce12eabc8f | 2025-11-06 | Warnings, Adverse reactions | 312840 WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | A-S Medication Solutions | 187204ef-5370-476a-84b1-e3c54b60c6c2 | 2025-11-06 | Warnings, Adverse reactions | 314209 WR978S7QHH |
| Rizatriptan | RIZATRIPTAN | A-S Medication Solutions | 34395ed2-97b7-4220-9089-0e90169d3083 | 2025-11-05 | Warnings, Adverse reactions | ANDA203147 314209 WR978S7QHH |
| REMEDY Calazime Skin Protectant | CALAMINE, MENTHOL, WHITE PETROLATUM, ZINC OXIDE | Medline Industries, LP | 1295cfcc-5b61-481b-964b-f53ffd0cb58e | 2025-10-30 | Warnings | 1K09F3G675 |
| Aveeno Anti-Itch Concentrated | ZINC OXIDE, FERRIC OXIDE RED, AND PRAMOXINE HYDROCHLORIDE | Kenvue Brands LLC | 07f4d4d0-9cee-46c3-bc71-2024abd31c9e | 2025-10-29 | Warnings | 1K09F3G675 |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS SPRAY | Premier Brands of America, Inc. | d3452573-f91f-f157-e053-2a95a90a1ad8 | 2025-10-27 | Warnings | 1K09F3G675 |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Advanced Rx of Tennessee, LLC | 4137a02e-dcec-c14c-e063-6294a90aa44f | 2025-10-21 | Warnings, Adverse reactions | WR978S7QHH |
| RIZATRIPTAN BENZOATE | RIZATRIPTAN BENZOATE | Creekwood Pharmaceuticals LLC | b517896b-167e-47d5-801d-7458f80e8ee2 | 2025-10-09 | Warnings, Adverse reactions | 314209 312840 WR978S7QHH |
| Powder | TITANIUM DIOXIDE | Oxygen Development LLC | 08b52f29-c1a0-c673-e063-6294a90a9a7a | 2025-09-05 | Warnings | 1K09F3G675 |
| Powder | TITANIUM DIOXIDE | Oxygen Development LLC | 08b8003f-40be-3380-e063-6294a90a4f6b | 2025-09-05 | Warnings | 1K09F3G675 |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Golden State Medical Supply, Inc. | 07605de4-bef2-70e8-e063-6394a90a33cc | 2025-08-20 | Warnings, Adverse reactions | WR978S7QHH |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS SPRAY | FSA Store Inc. | 3cd18f96-34f7-3f2c-e063-6294a90a3b7e | 2025-08-19 | Warnings | 1K09F3G675 |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Aurobindo Pharma Limited | a8e37688-426c-4290-933d-54a34ae86000 | 2025-08-06 | Warnings, Adverse reactions | WR978S7QHH |
| Ferrum rosatum Graphites | FERRUM ROSATUM GRAPHITES | Uriel Pharmacy Inc. | 1a4ca338-eada-4c0f-8bce-480244940c89 | 2025-06-27 | Warnings | 1K09F3G675 |
| Aquavit | AQUAVIT | Uriel Pharmacy Inc. | c1c0887a-c388-c737-e053-2a95a90a076c | 2025-06-06 | Warnings | 1K09F3G675 |
| Powder | TITANIUM DIOXIDE | Oxygen Development LLC | 08b7eeeb-09ae-ffe6-e063-6294a90aba90 | 2025-05-07 | Warnings | 1K09F3G675 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.